1.
|
Phase: Phase IV Type: Health services research, Treatment Status: Approved-not yet active Age: Over 18 Sponsor: Other Protocol IDs: CP005, NCT00385983
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 to 80 Sponsor: Other Protocol IDs: UKW-NUK-I-124, NCT01704586
|
|
3.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: UCL/10/0299, 2011-000144-21, Cancer Research UK, ISRCTN, NCT01398085
|
|
4.
|
Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: Estimabl, CSET 1216, NCT00435851
|
|
5.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2011-02530, 10-182-B, UCCRC-10-182-B, CDR0000685236, N01CM00071, 8317, NCT01208051
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00198, MC057H, CDR0000588044, N01CM00099, MAYO-MC057H, 7627, NCT00625846
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2013-00554, OSU 12154, N01CM00070, NCT01811212
|
|
8.
|
Phase: Phase II Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: PAZOTHYR, 2012-003162-41, NCT01813136
|
|
9.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 100 Sponsor: NCI, Other Protocol IDs: CDR0000522716, JHOC-J0628, NCT00416949
|
|
10.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-087, NCT01412762
|